基因擴增技術的全球市場規模、佔有率和成長分析：按技術和最終用戶分類 - 產業預測（2024-2031）

Global Gene Amplification Technologies Market Size, Share, Growth Analysis, By Technology(PCR, NASBA), By End user(Academic & research institutions, diagnostic labs) - Industry Forecast 2024-2031

出版日期: 2024年03月02日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球基因擴增技術市場規模將為39.6億美元，從2023年的43.6億美元擴大到2031年的93.4億美元，並預計在預測期內（2024-2031年）持續成長。年複合成長率為10%。

在分子生物學和診斷技術開拓的推動下，基因擴增技術的全球市場正經歷強勁成長。擴大在個人化醫療、生物技術研究和疾病診斷的應用是重要的動機。該產業以等溫擴增和聚合酵素鏈鎖反應（PCR）擴增方法為主，但基於 CRISPR 的擴增方法正變得越來越普及。北美由於其強大的研發和醫療基礎設施而佔據了重要的市場佔有率。由於醫療保健支出增加和技術使用增加，亞太地區正在經歷快速成長。隨著基因組學繼續影響醫學和研究領域，基因擴增技術市場預計將穩定成長。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲

競爭格局

前5名企業對比
主要企業市場定位（2021年）
主要市場參與者所採取的策略
關鍵成功策略
近期市集活動
主要企業市場佔有率（2021年）

主要企業簡介

Thermo Fisher Scientific（USA）
Roche Diagnostics（Switzerland）
Agilent Technologies（USA）
QIAGEN（Netherlands）
Bio-Rad Laboratories（USA）
Illumina（USA）
Beckman Coulter（USA）
Fluidigm Corporation（USA）
Merck KGaA（Germany）
BioMerieux（France）
GenMark Diagnostics（USA）
Cepheid（USA）
Luminex Corporation（USA）
Enzo Biochem（USA）
Takara Bio（Japan）
Sysmex Corporation（Japan）
Promega Corporation（USA）
Becton, Dickinson and Company（USA）
DiaSorin SpA（Italy）
Eppendorf（Germany）

簡介目錄

Product Code: SQMIG35H2150

Global Gene Amplification Technologies Market size was valued at USD 3.96 billion in 2022 and is poised to grow from USD 4.36 billion in 2023 to USD 9.34 billion by 2031, growing at a CAGR of 10% during the forecast period (2024-2031).

The development of molecular biology and diagnostics has led to a strong increase in the global market for gene amplification technologies. Personalized medicine, biotechnology research, and growing applications in disease diagnostics are important motivators. The industry is dominated by isothermal and polymerase chain reaction (PCR) amplification methods, however CRISPR-based amplification is becoming more and more popular. Due to its robust R&D and healthcare infrastructure, North America has a sizable market share. Asia-Pacific is growing quickly as a result of increased healthcare spending and technology usage. With genomics continuing to influence the medical and research fields, the market for gene amplification technologies is expected to grow steadily.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Gene Amplification Technologies Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Gene Amplification Technologies Market Segmental Analysis

One may divide the worldwide market for gene amplification technologies into three segments: technology, end-user, and geography. Some examples of technological segments are LAMP, NASBA, PCR, and others. Pharmaceutical firms, academic and research institutes, and diagnostic labs are examples of end-users. The market is split geographically into Latin America, North America, Europe, Asia Pacific, the Middle East, and Africa.

Drivers of the Global Gene Amplification Technologies Market

The global market for gene amplification technologies is expanding due to the growing need for customized treatment and biotechnology breakthroughs. These technologies allow for the accurate and efficient examination of genetic material for research and diagnostic reasons.

Restraints in the Global Gene Amplification Technologies Market

Market expansion is impeded by ethical concerns over genetic manipulation, intricate regulatory frameworks, and high costs linked to gene amplification technologies. These factors may limit the broad use and growth of these technologies in the worldwide market.

Market Trends of the Global Gene Amplification Technologies Market

Key developments in the global gene amplification technologies market include the quick development of CRISPR-Cas9 technology, which allows for accurate and effective gene editing. Market growth is being propelled by expanding applications in biotechnology, agriculture, and medical research. Furthermore, the need for gene amplification techniques is fueled by the growth of customized medicine and synthetic biology. Efficiency gains come from automation and high-throughput capacities. Nonetheless, there are still issues with genetic modification in terms of ethics and regulations. All things considered, the market is driven by innovation, a wide range of applications, and rising funding for genetic research, with an emphasis on both therapeutic and non-therapeutic uses.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Gene Amplification Technologies Market by Technology

Market Overview
PCR
NASBA
LAMP
and others

Global Gene Amplification Technologies Market by End user

Market Overview
Academic & research institutions
diagnostic labs
and pharmaceutical companies

Global Gene Amplification Technologies Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Thermo Fisher Scientific (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Diagnostics (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Beckman Coulter (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fluidigm Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioMerieux (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GenMark Diagnostics (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cepheid (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Luminex Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Enzo Biochem (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takara Bio (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sysmex Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Promega Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DiaSorin S.p.A. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eppendorf (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments